Why Biotech’s Trajectory Could Be Determined In June

Driven in part by an unusually large number of big-name disappointments, biotech stocks on the whole have been in decline since February – and whether that slide turns into a temporary slump or a full-on rout could be determined by a critical event in June.  CLICK HERE.